High level of C-reactive protein as a predictive factor for immune-related adverse events of immune checkpoint inhibitors in non-small cell lung cancer: a retrospective study

por Onodera, Ren, Chiba, Shinji, Nihei, Satoru, Fujimura, Itaru, Akiyama, Masachika, Utsumi, Yu, Nagashima, Hiromi, Kudo, Kenzo, Maemondo, Makoto
Publicado 2023

A Case of Mediastinal Tuberculous Lymphadenitis in a Chronic Dialysis Patient Diagnosed by Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA)

por Nagashima, Hiromi, Abe, Kazuyuki, Owada, Yukihiro, Yakuwa, Kazuhiro, Katagiri, Hiroshi, Chiba, Shinji, Matsumoto, Ami, Akiyama, Masachika, Utsumi, Yu, Maemondo, Makoto
Publicado 2023

Treatment with immune checkpoint inhibitors after EGFR‐TKIs in EGFR ‐mutated lung cancer

por Ito, Takashi, Nagashima, Hiromi, Akiyama, Masachika, Utsumi, Yu, Sato, Hideomi, Chiba, Shinji, Sugai, Mayu, Ube, Kenji, Mori, Yoshiaki, Watanabe, Kana, Fukuhara, Tatsuro, Maemondo, Makoto
Publicado 2021

Characteristics and prognostic analysis of patients with detected KRAS mutations in resected lung adenocarcinomas by peptide nucleic acid-locked nucleic acid polymerase chain react...

por Hashimoto, Tatsuya, Owada, Yoshihisa, Katagiri, Hiroshi, Yakuwa, Kazuhiro, Tyo, Katuya, Sugai, Mayu, Fuzimura, Itaru, Utsumi, Yu, Akiyama, Masachika, Nagashima, Hiromi, Terasaki, Hiroshi, Yanagawa, Naoki, Saito, Hajime, Sugai, Tamotsu, Maemondo, Makoto
Publicado 2023

Randomized phase II trial of uracil/tegafur and cisplatin versus pemetrexed and cisplatin with concurrent thoracic radiotherapy for locally advanced unresectable stage III non-squa...

por Watanabe, Kana, Toi, Yukihiro, Nakamura, Atsushi, Chiba, Ryosuke, Akiyama, Masachika, Sakakibara-Konishi, Jun, Tanaka, Hisashi, Yoshimura, Naruo, Miyauchi, Eisaku, Nakagawa, Taku, Igusa, Ryotaro, Minemura, Hiroyuki, Mori, Yoshiaki, Fujimoto, Keisuke, Matsushita, Haruo, Takahashi, Fumiaki, Fukuhara, Tatsuro, Inoue, Akira, Sugawara, Shunichi, Maemondo, Makoto
Publicado 2021